ImmuGlo HEp-2 Elite IFA

Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

IMMCO Diagnostics, Inc.

The following data is part of a premarket notification filed by Immco Diagnostics, Inc. with the FDA for Immuglo Hep-2 Elite Ifa.

Pre-market Notification Details

Device IDK172745
510k NumberK172745
Device Name:ImmuGlo HEp-2 Elite IFA
ClassificationAntinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Applicant IMMCO Diagnostics, Inc. 60 Pineview Dr. Buffalo,  NY  14228
ContactKevin Lawson
CorrespondentKevin Lawson
IMMCO Diagnostics, Inc. 60 Pineview Dr. Buffalo,  NY  14228
Product CodeDHN  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-09-12
Decision Date2018-06-05
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.